한글목차

세계 바이오 이미징 시장의 미래는 클리닉, 진단센터, 병원, 연구소 등 다양한 시장에서 기회로 인해 유망합니다. 세계 바이오 이미징 시장은 2025-2031년 15.7%의 연평균 복합 성장률(CAGR)로 2031년까지 약 197억 달러에 달할 것으로 예측됩니다. 이 시장의 주요 촉진요인은 이미징 기술의 발전에 따른 바이오 이미징 기기에 대한 수요 증가, 만성 질환의 유병률 증가와 세계 인구의 고령화, 진단센터 및 방사성의약품 증가입니다.

• Lucintel의 예측에 따르면, 유형별로는 엑스레이 촬영이 응급의료, 정형외과, 일반 방사선과에서 채용이 증가함에 따라 예측 기간 동안 가장 높은 성장세를 보일 것으로 예상됩니다.
• 최종 용도별로는 병원이 가장 큰 부문을 차지할 것으로 예상됩니다. 이는 병원의 운영 효율화를 위한 인프라 및 첨단 영상 처리 시설의 개발이 눈에 띄게 발전하고 있기 때문입니다.
• 지역별로 보면, 북미는 의료시스템의 확립, 정교한 의료시설, 암과 심장질환의 발병률 증가, 특히 미국의 높은 의료보험제도 보급률로 인해 예측기간 동안 북미가 가장 규모가 큰 지역으로 남을 것으로 보입니다.

바이오 이미징 시장의 전략적 성장 기회

바이오 이미징 시장은 기술 혁신, 더 나은 진단에 대한 수요, 의료 기술의 발전으로 인해 새로운 전략적 성장 기회를 발견하고 있습니다. 이러한 기회는 성장 시장에 진입하고 혁신을 추구하는 이해관계자들에게 매우 중요합니다. 이 섹션에서는 바이오 이미징 시장과 의료의 미래에서 용도별 5가지 성장 기회와 그 역할에 대해 살펴봅니다.

• 종양 이미징: 암 발병률이 증가함에 따라 종양 이미징은 바이오 이미징 시장의 주요 성장 분야로 PET/CT, PET/MRI, 분자 이미징과 같은 첨단 이미징 장비는 암의 정확한 진단 및 치료 계획에 사용되고 있습니다. 종양학 영상에 AI를 통합하면 종양 식별 정확도를 높이고, 개인화된 치료 계획을 수립할 수 있습니다. 이러한 성장 기회는 첨단 영상 솔루션 개발에 대한 투자로 이어져 종양학 관점에서 시장이 확대되고 있습니다.
• 신경학 영상: 알츠하이머병, 파킨슨병, 다발성 경화증과 같은 신경질환의 유병률이 증가함에 따라 신경학 영상도 주요 성장 분야입니다. 기능적 MRI(fMRI), 확산텐서영상(DTI), PET와 같은 새로운 영상기술이 이러한 질환의 진단과 평가에 사용되고 있습니다. 또한, 병변 및 악성 종양의 신속한 스크리닝 및 검출에 대한 수요 증가에 대응하기 위해 영상 진단법도 진화하고 있습니다. 이러한 추세는 신경과를 대상으로 하는 영상 솔루션의 성장 기회를 창출하고 있습니다.
• 심장학 영상: 심혈관 질환의 유병률 증가와 정확한 진단의 필요성으로 인해 심혈관 영상진단 시장은 지속적으로 성장하고 있으며, 3D 및 4D 심초음파, 심장 MRI, CT 혈관조영술과 같은 첨단 영상기술의 사용으로 수술 없이도 심장을 안전하게 평가할 수 있는 방법이 제공되고 있습니다. 기반 도구도 심장 질환 진단 시스템에 통합되어 심장 질환의 진단을 강화하고 업무 효율성을 향상시키고 있습니다. 이러한 시장 성장은 심장 영상 기술의 발전을 촉진하고 환자 치료를 개선하는 데 기여하고 있습니다.
• 정형외과 영상: 정형외과 영상 시장은 인구 고령화와 근골격계 질환의 유병률 증가로 인해 확대되고 있습니다. 정형외과 영상 기술은 진단에 도움이 될 뿐만 아니라 치료 계획과 재활을 위한 지침이 되기도 합니다. 모바일 영상진단 장비는 적시 진단과 치료 개입이 중요한 정형외과 진료에 특히 유용합니다. 이러한 추세는 정형외과 영상 솔루션에 대한 수요를 증가시키고 첨단 영상 기술 개발을 촉진하고 있습니다.
• 수의학 이미징: 수의학 이미징은 동물 의료 분야의 고급 진단 도구에 대한 수요에 힘입어 바이오 이미징 시장의 성장에 크게 기여하고 있습니다. 초음파, MRI, CT와 같은 기술은 동물 의료에 비침습적 솔루션을 제공하는 수의 진단에 점점 더 많이 사용되고 있습니다. 또한, 동물 의료용 AI 기반 영상 솔루션의 개발로 진단 정확도와 워크플로우 효율성이 향상되고 있습니다. 이러한 성장 기회는 바이오 이미징 시장 확대의 새로운 길을 열어주고 있습니다.

바이오 이미징 시장은 기술 발전과 정확하고 효과적인 진단 도구에 대한 수요 증가로 인해 크게 성장하고 있습니다. 이러한 추세는 종양학, 신경학, 심장학, 정형외과, 수의학 등 다양한 분야에서 새로운 성장 기회를 창출하고 있습니다.

바이오 이미징 시장 활성화 요인 및 과제

바이오 이미징 시장은 기술 발전, 경제 상황, 규제 정책 등 여러 가지 시장 성장 촉진요인 및 과제에 영향을 받습니다. 이러한 요인은 시장 성장, 이미징 기술의 고객 수용, 전체 산업 구조를 결정하는 데 중요한 역할을 합니다.

성장 촉진요인:

• 이미징 양식의 기술 향상: AI, 하이브리드 양식, 무선 이미징 시스템 통합 등 이미징 기술의 끊임없는 개선이 바이오 이미징 시장의 성장을 가속하고 있습니다. 이러한 기술 혁신은 진단의 정확성과 속도를 향상시켜 시장 확대에 기여하고 있습니다.
• 만성질환 발생률 증가: 암, 심혈관질환, 신경질환 등 만성질환의 유병률 증가로 인해 첨단 영상진단 기술에 대한 수요가 증가하고 있습니다. 신속하고 정확한 진단의 필요성이 첨단 영상 기술의 채택을 촉진하고 있습니다.
• 표적치료에 대한 관심 증가: 개인 맞춤형 의료에 대한 관심이 높아지면서 3D 및 4D 이미징과 같은 고해상도 첨단 이미징 시스템에 대한 수요가 증가하고 있습니다. 이러한 기술을 통해 보다 맞춤화된 치료 접근이 가능해져 환자의 예후를 개선할 수 있습니다.
• 의료비 증가: 각국 정부 및 민간 투자자들의 의료비 지출 증가는 첨단 영상 기술의 사용을 촉진하고 있습니다. 특히 신흥국들의 의료시설 확충은 영상 솔루션 제공업체들에게 새로운 성장 기회를 제공합니다.
• 유리한 규제 승인 및 상환 정책: 규제 당국의 승인 및 상환 제도는 침습적 영상 기술의 채택을 촉진하고 혁신적인 장비 개발에 대한 투자를 장려하고 있습니다.

과제:

• 첨단 영상 시스템의 높은 비용: 특히 의료 예산이 한정된 신흥국에서는 첨단 영상 진단 시스템의 높은 비용이 큰 문제입니다. 이 장벽은 첨단 영상 기술의 채택을 억제하고 시장 성장을 둔화시키는 요인으로 작용하고 있습니다.
• 데이터 프라이버시 및 보안에 대한 우려: 클라우드 기반 이미지 처리 플랫폼과 AI를 활용한 용도의 도입이 증가함에 따라 데이터 프라이버시 및 보안에 대한 우려가 커지고 있습니다. 의료 제공업체와 환자의 신뢰 관계를 구축하기 위해서는 규제 준수와 기밀 데이터 보호가 필수적입니다.
• 숙련된 인력 부족: 바이오 이미징 분야의 숙련된 전문가가 부족하여 첨단 이미징 기술을 충분히 활용하지 못하고 있습니다. 이 문제는 고급 영상 처리 시스템 운영에 대한 전문 지식이 부족한 개발도상국에서 특히 두드러집니다.

바이오 이미징 시장이 직면한 촉진 및 저해요인은 향후 시장 동향을 형성하고 신기술 개발 및 이미징 서비스 확대에 영향을 미칩니다. 이러한 과제를 해결함으로써 이해관계자들은 시장의 새로운 기회를 활용할 수 있습니다.

목차

제1장 주요 요약

제2장 세계의 바이오 이미징 시장 : 시장 역학

• 서론, 배경, 분류
• 공급망
• 업계 촉진요인과 과제

제3장 시장 동향과 예측 분석(2019년-2031년)

• 거시경제 동향(2019-2024년)과 예측(2025-2031년)
• 세계의 바이오 이미징 시장 동향(2019-2024년)과 예측(2025-2031년)
• 세계의 바이오 이미징 시장 : 유형별
  • Elastography
  • 자기공명영상(MRI)
  • 의료용 초음파 검사/초음파
  • X선 촬영
• 세계의 바이오 이미징 시장 : 기술별
  • 의학
  • 분자
• 세계의 바이오 이미징 시장 : 최종 용도별
  • 클리닉
  • 진단센터
  • 병원
  • 연구소

제4장 지역별 시장 동향과 예측 분석(2019년-2031년)

• 세계의 바이오 이미징 시장 : 지역별
• 북미의 바이오 이미징 시장
• 유럽의 바이오 이미징 시장
• 아시아태평양의 바이오 이미징 시장
• 기타 지역의 바이오 이미징 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영 통합
• Porter의 Five Forces 분석

제6장 성장 기회와 전략 분석

• 성장 기회 분석
  • 세계의 바이오 이미징 시장 성장 기회 : 유형별
  • 세계의 바이오 이미징 시장 성장 기회 : 기술별
  • 세계의 바이오 이미징 시장 성장 기회 : 최종 용도별
  • 세계의 바이오 이미징 시장 성장 기회 : 지역별
• 세계 바이오 이미징 시장의 새로운 동향
• 전략적 분석
  • 신제품 개발
  • 세계의 바이오 이미징 시장 생산능력 확대
  • 세계 바이오 이미징 시장 기업인수합병(M&A), 합병사업
  • 인증 및 라이선싱

제7장 주요 기업 개요

• Bioclinica
• Bracco Imaging
• FONAR
• Bayer Healthcare Pharmaceuticals
• Covidin corp
• GE Healthcare
• GammaMedica

영문목차

The future of the global bio-imaging market looks promising with opportunities in the clinic, diagnostic center, hospital, and laboratory markets. The global bio-imaging market is expected to reach an estimated $19.7 billion by 2031 with a CAGR of 15.7% from 2025 to 2031. The major drivers for this market are the increasing demand for bioimaging instruments as an advancement in the imaging technologies, the rising prevalence of chronic diseases and the a aging world population, and the increasing number of diagnostic centers and radiopharmaceuticals.

• Lucintel forecasts that, within the type category, X-ray radiography is expected to witness the highest growth over the forecast period due to its increasing adoption of emergency medicine, orthopedics, and general radiology.
• Within the end use category, hospitals will remain the largest segment due to significantly growing developed infrastructure and advanced imaging facilities that enable hospitals to streamline their operations.
• In terms of regions, North America will remain the largest region during the forecast period due to the presence of well-established healthcare systems, sophisticated medical facilities, increasing incidence of cancer and cardiac diseases, and high adoption of healthcare insurance policies among the population particularly in the USA.

Gain Valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Bio-Imaging Market

The bio-imaging industry is undergoing significant changes driven by new trends expected to transform the market. These trends are influenced by advancements in technology, the increasing demand for reliable and rapid diagnosis, and the integration of emerging modalities with artificial intelligence (AI) and machine learning. Several general trends are emerging as the market evolves. Some of the visible trends include the adoption of hybrid imaging techniques, developments in portable imaging solutions, and the utilization of cloud-based platforms. This section highlights five key emerging trends in the bio-imaging market, focusing on their implications for access to health services, diagnostic accuracy, and market growth.

• Integration of Imaging with AI: The integration of imaging with AI is a rapidly growing trend in the bio-imaging market, leading to improved accuracy and efficiency in imaging solutions. By utilizing deep learning technologies, AI can identify shapes and contours that may be missed by the human eye, especially in detecting diseases at early stages. AI also enables real-time analysis, reducing delays in diagnostics and facilitating faster decision-making. AI imaging tools are becoming more prominent in individualized treatment planning, where treatment approaches are based on patient-specific imaging data. This trend is accelerating the development of new imaging techniques and enhancing healthcare processes.
• Overlapping Imaging Technologies: Market intelligence reports indicate that the application of overlapping imaging technologies, such as PET/MRI and SPECT/CT, is becoming increasingly important. These systems combine the advantages of multiple imaging modalities to create comprehensive central images, improving diagnostic accuracy. For example, PET/MRI combines PET imaging of metabolic changes with MRI imaging of soft tissue structures, providing both functional and anatomical insights into pathological processes. Hybrid imaging is particularly beneficial for diagnosing cancer, heart disease, and brain conditions, where understanding both the problem and its treatment is critical. This development is contributing to the emergence of more flexible and advanced imaging systems.
• Portable and Point-of-Care Imaging Devices: The demand for portable and point-of-care imaging devices is rising, particularly in rural and remote areas where healthcare facilities require portable and easy-to-use solutions. Devices like portable ultrasound and handheld MRI are enabling doctors to conduct bedside diagnostics, providing faster and more convenient care for patients. These devices are especially important in emergencies, where rapid diagnostics can save lives. Additionally, advancements in miniaturization and wireless technology are enhancing the functionality of portable imaging systems, making them an integral part of modern healthcare.
• Platforms for Imaging Hosted in the Cloud: Cloud-based imaging platforms are transforming how imaging data is captured, stored, shared, and analyzed. These platforms enable integration with electronic health records and telehealth systems, providing users with access to imaging data regardless of their location. One of the key advantages of cloud platforms is collaborative diagnostics, where multiple healthcare providers can access and interpret the same data simultaneously. These platforms also address concerns related to data ownership, security, and access, making them a critical trend in the bio-imaging industry. As data privacy and security issues are resolved, this trend is expected to grow.
• Precision Oncology as a Course of Action in Theragnostic Research and Molecular Imaging: Molecular imaging and theragnostics are becoming increasingly important in oncology. These technologies enable imaging of both anatomical and pathological processes in the body, highlighting changes that can guide treatment decisions. The use of theragnostic agents, which combine diagnostic and therapeutic functions, is leading to more personalized treatments. The growing use of PET/CT and PET/MRI as molecular imaging techniques is facilitating the development of improved targeted radiopharmaceuticals for both diagnostic and therapeutic purposes.

The trends observed in the bio-imaging sector are transforming how healthcare services are delivered by increasing diagnostic and treatment efficiency, reducing costs, and enhancing patient satisfaction. These trends play a key role in driving the growth and advancement of the market, opening up new opportunities for market players.

Recent Developments in the Bio-Imaging Market

The bio-imaging market is undergoing significant changes that are reshaping its structure. Key developments include the integration of new imaging systems with AI, as well as strategic partnerships that are boosting market progress. The entry of miniaturized imaging devices, networked applications, and novel imaging modalities is enabling more accurate and timely diagnoses. These improvements are essential for the healthcare system, ensuring better patient care, streamlining processes, and supporting targeted treatments. This section focuses on five key areas of growth within the bio-imaging industry.

• AI-Based Imaging Tools: New AI-based imaging tools are making diagnoses more effective and expediting analysis in the bio-imaging industry. These tools use algorithms and data analysis to enhance the screening process for various diseases. AI-enhanced imaging devices are also helping develop patient-specific treatment plans, particularly for cancer and neurological diseases. This growing use of modern imaging technologies is creating a market for AI-powered bio-imaging solutions.
• Introduction of Cloud-Based Imaging Platforms: The introduction of cloud-based imaging platforms is a significant development in the bio-imaging industry. These platforms enable the secure storage, sharing, and analysis of imaging data, fostering collaboration among healthcare providers. Remote access to imaging data is particularly important for telemedicine and remote diagnostics. These platforms also address challenges related to data storage and management, offering solutions that meet the needs of users while accommodating increasing volumes of digital health tools.
• Introduction of Hybrid Imaging Systems: Hybrid imaging systems, such as PET/CT, PET/MRI, and SPECT/CT, combine multiple imaging modalities to provide a more comprehensive view of the body. The information from these systems is integrated to deliver both anatomical and functional insights, enhancing diagnostic accuracy. Hybrid imaging is particularly useful in oncology, cardiology, and neurology, where diagnostic precision is critical. The next generation of hybrid imaging systems is expected to bring further innovation and market expansion.
• Collaboration and Strategic Partnerships: Innovation in the bio-imaging market is being driven by collaboration and strategic partnerships between key players, including medical device companies, research institutions, and service providers. These partnerships are helping to accelerate the development and adoption of new imaging technologies.

Recent developments in bio-imaging, such as improvements in non-invasive probes, are enhancing the capabilities of imaging systems, improving patient treatment, and driving market growth. These developments are creating favorable conditions for stakeholders and offering new opportunities within the healthcare sector.

Strategic Growth Opportunities for Bio-Imaging Market

The bio-imaging market is identifying new strategic growth opportunities, driven by technological innovation, the demand for better diagnosis, and advancements in healthcare technology. These opportunities are crucial for stakeholders entering the growing market and pursuing innovations. This section outlines five growth opportunities by application and their roles in the bio-imaging market and the future of healthcare.

• Oncology Imaging: Oncology imaging is a major growth segment in the bio-imaging market due to the increasing incidence of cancer. Advanced imaging devices such as PET/CT, PET/MRI, and molecular imaging are used for accurate cancer diagnosis and treatment planning. The integration of AI in oncology imaging is improving the precision of tumor identification and enabling personalized treatment plans. This growth opportunity is attracting investment in the development of advanced imaging solutions, expanding the market from an oncology perspective.
• Neurology Imaging: Neurology imaging is another key growth segment due to the rising prevalence of neurological conditions such as Alzheimer's, Parkinson's disease, and multiple sclerosis. New imaging techniques, including functional MRI (fMRI), diffusion tensor imaging (DTI), and PET, are being used to diagnose and assess these diseases. Imaging methods are also evolving to meet the growing demand for rapid screening and detection of lesions and malignancies. This trend is creating growth opportunities for imaging solutions targeting neurology.
• Cardiology Imaging: The cardiology imaging market continues to grow due to the increasing incidence of cardiovascular diseases and the need for accurate diagnosis. The use of advanced imaging techniques such as 3D and 4D echocardiography, cardiac MRI, and CT angiography is providing safer ways to assess the heart without surgery. AI-based tools are also being integrated into cardiology imaging systems to enhance the diagnosis of heart diseases and improve operational efficiency. This market growth is spurring advances in cardiac imaging technologies, improving patient care.
• Orthopedic Imaging: The orthopedic imaging market is expanding due to the aging population and the rising prevalence of musculoskeletal disorders. Imaging techniques in orthopedics are not only helping with diagnosis but also guiding treatment planning and rehabilitation. Mobile imaging devices are particularly valuable in orthopedic practices, where timely diagnostics and therapeutic interventions are critical. This trend is increasing the demand for orthopedic imaging solutions and driving the development of advanced imaging techniques.
• Veterinary Imaging: Veterinary imaging is emerging as a key contributor to the growth of the bio-imaging market, driven by the demand for more sophisticated diagnostic tools in the animal health sector. Techniques such as ultrasound, MRI, and CT are increasingly being used for veterinary diagnostics, offering non-invasive solutions for animal care. Additionally, the development of AI-driven imaging solutions for veterinary care is enhancing diagnostic accuracy and workflow efficiency. This growth opportunity is unlocking new avenues for expansion in the bio-imaging market.

The bio-imaging market is experiencing significant growth due to advancements in technology and the increasing demand for accurate and effective diagnostic tools. These trends are creating new growth opportunities in various sectors, including oncology, neurology, cardiology, orthopedics, and veterinary care.

Bio-Imaging Market Driver and Challenges

The bio-imaging market is influenced by several drivers and challenges, including technological advancements, economic conditions, and regulatory policies. These factors play a crucial role in determining market growth, customer acceptance of imaging technologies, and the overall structure of the industry.

Drivers:

• Technological Improvements in Imaging Modalities: Continuous improvements in imaging technologies, such as the integration of AI, hybrid modalities, and wireless imaging systems, are driving growth in the bio-imaging market. These innovations are improving diagnostic accuracy and speed, contributing to market expansion.
• Rising Incidence of Chronic Diseases: The growing prevalence of chronic diseases, including cancer, cardiovascular diseases, and neurological conditions, is increasing the demand for advanced imaging techniques. The need for swift and accurate diagnosis is driving the adoption of state-of-the-art imaging technologies.
• Increased Interest in Targeted Medicine: The growing trend of personalized medicine is driving demand for advanced imaging systems with high resolution, such as 3D and 4D imaging. These technologies are enabling more tailored therapeutic approaches, leading to better patient outcomes.
• Increase in Health Expenditure: Rising healthcare spending from both national governments and private investors is promoting the use of advanced imaging techniques. The improvement of healthcare facilities, especially in developing countries, is opening new growth opportunities for imaging solution providers.
• Favorable Regulatory Approvals and Reimbursement Policies: Regulatory approvals and reimbursement schemes are facilitating the adoption of invasive imaging technologies and encouraging investment in innovative equipment development.

Challenges:

• High Cost of Advanced Imaging Systems: The high cost of advanced imaging systems is a major challenge, especially in developing countries with limited medical budgets. This barrier reduces the adoption of cutting-edge imaging technologies, slowing market growth.
• Concerns About Data Privacy and Security: The increased adoption of cloud-based imaging platforms and AI-powered applications has raised concerns about data privacy and security. Ensuring compliance with regulations and protecting sensitive data is critical to building trust among healthcare providers and patients.
• Shortage of Skilled Workforce: A shortage of skilled professionals in the bio-imaging sector is preventing the full utilization of advanced imaging technologies. This challenge is particularly prevalent in developing regions, where expertise in operating sophisticated imaging systems is limited.

The drivers and challenges facing the bio-imaging market will shape its future trends, influencing the development of new technologies and the expansion of imaging services. Addressing these challenges will help stakeholders leverage emerging opportunities in the market.

List of Bio-Imaging Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies bio-imaging companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the bio-imaging companies profiled in this report include-

• Bioclinica
• Bracco Imaging
• Fonar
• Bayer Healthcare Pharmaceuticals
• Covidin
• GE Healthcare
• Gammamedica

Bio-Imaging by Segment

The study includes a forecast for the global bio-imaging market by type, technology, end use, and region.

Bio-Imaging Market by Type [Analysis by Value from 2019 to 2031]:

• Elastography
• Magnetic Resonance Imaging
• Medical Ultrasonography or Ultrasound
• X-Ray Radiography

Bio-Imaging Market by Technology [Analysis by Value from 2019 to 2031]:

• Medical
• Molecular

Bio-Imaging Market by End Use [Analysis by Value from 2019 to 2031]:

• Clinics
• Diagnostic Centers
• Hospitals
• Laboratories

Bio-Imaging Market by Region [Analysis by Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Bio-Imaging Market

The global bio-imaging market is undergoing significant advancements due to technological innovations, increased healthcare spending, and the rising demand for accurate diagnosis. Countries such as the United States, China, Germany, India, and Japan are at the forefront of these developments, each contributing distinct advancements that will impact the global market. Key trends include the introduction of AI, the exploration of new imaging modalities, and the formation of alliances among industry players. This section summarizes the developments in each of these countries, highlighting key trends and advancements in the bio-imaging sector.

• United States: The bio-imaging market in the United States is rapidly evolving, with a strong focus on integrating AI into imaging technologies. Partnerships between companies and research institutions are driving innovation, especially in the early diagnosis of diseases like cancer and neurological disorders. The U.S. FDA's approval of new imaging devices has improved diagnostic capabilities, while public interest in personalized medicine is pushing the demand for modern 3D and 4D imaging systems. Additionally, there is growing interest in cloud-based solutions for remote diagnostics.
• China: China's bio-imaging market is growing quickly, fueled by expanding healthcare infrastructure and a focus on local innovation. The country is adopting advanced imaging techniques, including molecular imaging and AI-based diagnostic tools. Chinese companies are forming alliances with international firms to enhance technological capabilities. Government policies supporting medical device innovation have led to the production of cost-effective yet sophisticated imaging systems. An aging population and the rising incidence of chronic diseases are further driving the demand for bio-imaging solutions.
• Germany: Germany continues to be a leader in the bio-imaging market, benefiting from its high-quality healthcare system and innovative developments. Recent advancements include the use of computer-aided detection (CAD) and image analysis (IA) systems to improve diagnostic performance. The adoption of hybrid imaging systems, such as PET/MRI and SPECT/CT, is also on the rise. Collaboration between hospitals, research institutions, and companies is fostering innovation, particularly in precision medicine for cancer and neurological diseases.
• India: India is experiencing steady growth in the bio-imaging market, with a focus on cost-effective and high-quality imaging solutions. The demand for imaging tools is increasing in rural areas, where remote diagnostics and AI-powered systems are playing a significant role. Government initiatives, such as the "Make in India" program, are promoting the development of homegrown bio-imaging technologies, making them more affordable and accessible. Public-private partnerships are also helping expand the availability of advanced imaging systems across the country.
• Japan: Japan's bio-imaging market is advancing rapidly, with a strong emphasis on new technologies such as 4D MRI and high-frequency ultrasound for better diagnostic imaging. The government is actively supporting the development of advanced imaging systems, and portable imaging devices combined with AI are becoming increasingly popular, especially for elderly care. Research on the longitudinal adoption of these technologies is also underway, with a focus on early diagnosis and patient comfort.

Features of the Global Bio-Imaging Market

Market Size Estimates: Bio-imaging market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Bio-imaging market size by type, technology, end use, and region in terms of value ($B).

Regional Analysis: Bio-imaging market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, technologies, end uses, and regions for the bio-imaging market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the bio-imaging market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the bio-imaging market by type (elastography, magnetic resonance imaging, medical ultrasonography or ultrasound, and X-ray radiography), technology (medical and molecular), end use (clinics, diagnostic centers, hospitals, and laboratories), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Bio-Imaging Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Bio-Imaging Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Bio-Imaging Market by Type
  • 3.3.1: Elastography
  • 3.3.2: Magnetic Resonance Imaging
  • 3.3.3: Medical Ultrasonography or Ultrasound
  • 3.3.4: X-ray Radiography
• 3.4: Global Bio-Imaging Market by Technology
  • 3.4.1: Medical
  • 3.4.2: Molecular
• 3.5: Global Bio-Imaging Market by End Use
  • 3.5.1: Clinics
  • 3.5.2: Diagnostic Centers
  • 3.5.3: Hospitals
  • 3.5.4: Laboratories

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Bio-Imaging Market by Region
• 4.2: North American Bio-Imaging Market
  • 4.2.1: North American Market by Type: Elastography, Magnetic Resonance Imaging, Medical Ultrasonography or Ultrasound, and X-ray Radiography
  • 4.2.2: North American Market by End Use: Clinics, Diagnostic Centers, Hospitals, and Laboratories
• 4.3: European Bio-Imaging Market
  • 4.3.1: European Market by Type: Elastography, Magnetic Resonance Imaging, Medical Ultrasonography or Ultrasound, and X-ray Radiography
  • 4.3.2: European Market by End Use: Clinics, Diagnostic Centers, Hospitals, and Laboratories
• 4.4: APAC Bio-Imaging Market
  • 4.4.1: APAC Market by Type: Elastography, Magnetic Resonance Imaging, Medical Ultrasonography or Ultrasound, and X-ray Radiography
  • 4.4.2: APAC Market by End Use: Clinics, Diagnostic Centers, Hospitals, and Laboratories
• 4.5: ROW Bio-Imaging Market
  • 4.5.1: ROW Market by Type: Elastography, Magnetic Resonance Imaging, Medical Ultrasonography or Ultrasound, and X-ray Radiography
  • 4.5.2: ROW Market by End Use: Clinics, Diagnostic Centers, Hospitals, and Laboratories

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Bio-Imaging Market by Type
  • 6.1.2: Growth Opportunities for the Global Bio-Imaging Market by Technology
  • 6.1.3: Growth Opportunities for the Global Bio-Imaging Market by End Use
  • 6.1.4: Growth Opportunities for the Global Bio-Imaging Market by Region
• 6.2: Emerging Trends in the Global Bio-Imaging Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Bio-Imaging Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Bio-Imaging Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Bioclinica
• 7.2: Bracco Imaging
• 7.3: FONAR
• 7.4: Bayer Healthcare Pharmaceuticals
• 7.5: Covidin corp
• 7.6: GE Healthcare
• 7.7: GammaMedica